Diabetes News and Research

Latest Diabetes News and Research

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

Kaiser Permanente Southern California selected for 10-center Mental Health Research Network

The Kaiser Permanente Southern California Department of Research & Evaluation has been selected for inclusion in the 10-center Mental Health Research Network (MHRN) recently funded with a $10.5 million grant from the National Institute of Mental Health. The five other Kaiser Permanente research centers included in the MHRN are located in Northern California, Oregon, Colorado, Georgia, and Hawaii.

9 Feb 2011

Researchers find large variations in quality and safety across diabetes websites

Nearly one-half of U.S. adults who use the Internet participate in social networks. While these increasingly include health-focused networks, not much is known about their quality and safety. In one of the first formal studies of social networking websites targeting patients, researchers in the Children's Hospital Boston Informatics Program performed an in-depth evaluation of ten diabetes websites.

9 Feb 2011

Chief medical officer offers tips to women for better heart health

With Valentine's Day on the horizon, most people's thoughts turn to matters of the heart. Although it's great fun to play Cupid this time of year, February is also American Heart Month — an important time for women in particular to understand their health risks.

9 Feb 2011

Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.

9 Feb 2011

Study finds low awareness about kidney risks posed by diabetes

The first time that many patients realise that diabetes can affect their kidneys is when they are referred to renal services, according to a multi-cultural study in the March issue of the Journal of Renal Care.

9 Feb 2011

Study: Financial incentives increased employee participation in health improvement programs

Fidelity Investments, a leading service provider of employer benefits, in conjunction with the National Business Group on Health, released a study today that found financial incentives have taken on greater importance in the drive to increase employee participation in health improvement programs.

9 Feb 2011

Canadian Diabetes Association releases Saskatchewan Diabetes Cost Model report

Today, the Canadian Diabetes Association released the findings from its Saskatchewan Diabetes Cost Model, indicating that Saskatchewan currently faces the highest combined prevalence of diabetes and prediabetes in the Prairies. The model shows that without action, the cost and prevalence of diabetes in the province will continue to increase substantially over the next 10 years.

9 Feb 2011

Prolonged sleep deprivation can lead to long-term, serious health implications

New research from Warwick Medical School published today in the European Heart Journal shows that prolonged sleep deprivation and disrupted sleep patterns can have long-term, serious health implications. Leading academics from the University have linked lack of sleep to strokes, heart attacks and cardiovascular disorders which often result in early death.

9 Feb 2011

Study finds link between sleep duration and colorectal adenomas

An inadequate amount of sleep has been associated with higher risks of obesity, heart disease, diabetes, and death. Now colon cancer can be added to the list.

9 Feb 2011

ASBP concerned over FDA rejection of Contrave drug

The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.

8 Feb 2011

Study estimates 1.3 million cancer deaths in Europe in 2011

There will be nearly 1.3 million deaths from cancer in Europe in 2011 according to predictions from a study published in the cancer journal, Annals of Oncology today.

8 Feb 2011

Australian teenagers could see declines in life expectancy and more heart problems: Study

Experts warn that the present generation of Australian teenagers could be the first with a decline in life expectancy and an increase in heart disease. This comes from the first comprehensive national study of young Australians since 1985 that shows that a quarter are overweight or obese.

8 Feb 2011

Avandia label revised as per FDA directive

Following the 2010 FDA directive, pharmaceutical manufacturer Glaxo-SmithKline announced this Monday that they have modified the label for diabetes drug rosiglitazone (Avandia). The new label restricts its use to patients already taking it or to those who have failed other antiglycemic drugs.

8 Feb 2011

New DGA urge Americans to reduce sodium intake, consume walnuts for 'good' fat

The 2010 U.S. Dietary Guidelines for Americans urge Americans to reduce their sodium intake, replace saturated and trans fats with the "good" fats and to lower cholesterol consumption.

8 Feb 2011

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others in the U.S. and Japan.

8 Feb 2011

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.

8 Feb 2011

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Transition Therapeutics Inc., a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2010.

8 Feb 2011

Study reports significant decline in second-generation medication use for dementia

As loved ones with dementia disappear into symptoms of aggression, agitation or delusions, families are left with few good medical solutions. A new generation of antipsychotic medications gained popularly in the 1990s because they avoided side effects such as Parkinson's syndrome associated with conventional antipsychotic medications used to treat dementia.

8 Feb 2011

Obesity rates double worldwide

The latest research has shown that obesity is on the rise worldwide and has actually doubled since 1980. On the other hand people in the developed countries have also managed to reduce their blood pressure and cholesterol levels. This comes from three new studies published online Feb. 3 in The Lancet.

7 Feb 2011

Diabetes News and Research

Latest Diabetes News and Research

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

Kaiser Permanente Southern California selected for 10-center Mental Health Research Network

Researchers find large variations in quality and safety across diabetes websites

Chief medical officer offers tips to women for better heart health

Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis

Study finds low awareness about kidney risks posed by diabetes

Study: Financial incentives increased employee participation in health improvement programs

Canadian Diabetes Association releases Saskatchewan Diabetes Cost Model report

Prolonged sleep deprivation can lead to long-term, serious health implications

Study finds link between sleep duration and colorectal adenomas

ASBP concerned over FDA rejection of Contrave drug

Study estimates 1.3 million cancer deaths in Europe in 2011

Australian teenagers could see declines in life expectancy and more heart problems: Study

Avandia label revised as per FDA directive

New DGA urge Americans to reduce sodium intake, consume walnuts for 'good' fat

Scientists develop low cost, nanometer-sized drug to treat chronic wounds

ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch

Transition reports second quarter 2011 net income of $24.28M vs. $6.05M net loss for second quarter 2010

Study reports significant decline in second-generation medication use for dementia

Obesity rates double worldwide

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in